DMC Data Monitoring Committee
Showing 1 - 25 of >10,000
Osteoarthritis, Knee Trial in United States (FX201)
Active, not recruiting
- Osteoarthritis, Knee
- FX201
-
Birmingham, Alabama
- +7 more
Dec 16, 2021
Hypertension, Diabete Mellitus Trial (O2O digital healthcare service)
Not yet recruiting
- Hypertension
- Diabete Mellitus
- O2O digital healthcare service
- (no location specified)
Nov 28, 2023
Esophageal Diseases Trial (Cellspan™ Esophageal Implant-Adult (CEI))
Not yet recruiting
- Esophageal Diseases
- Cellspan™ Esophageal Implant-Adult (CEI)
- (no location specified)
May 26, 2023
Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255
Recruiting
- Non-Hodgkin Lymphoma
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NKTR-255 at 1.5 µg/kg
- +3 more
-
La Jolla, California
- +26 more
Jan 10, 2023
Pneumococcal Infections, Pneumonia, Pneumococcal Trial in United States (Prevnar 13, AFX3772)
Recruiting
- Pneumococcal Infections
- Pneumonia, Pneumococcal
- Prevnar 13
- AFX3772
-
Jonesboro, Arkansas
- +31 more
Jan 19, 2023
Neurological Disorder Trial in Bloomfield (Glyceryl Tribenzoate)
Recruiting
- Neurological Disorder
- Glyceryl Tribenzoate
-
Bloomfield, New JerseyTKL Research
Jul 3, 2023
Severe Hemophilia A Trial in Sofia (OCTA101)
Terminated
- Severe Hemophilia A
-
Sofia, BulgariaSpecialized Hospital for Active Treatment of Hematological Disea
Mar 31, 2022
Retinitis Pigmentosa Trial in Tuebingen (subretinal injection of rAAV.hPDE6A)
Active, not recruiting
- Retinitis Pigmentosa
- subretinal injection of rAAV.hPDE6A
-
Tuebingen, GermanyUniversitätsklinikum Tübingen, Department für Augenheilkunde
Dec 7, 2022
Tuberculosis, Pulmonary Trial in Cape Town (SeroSelectTB rapid TB test)
Recruiting
- Tuberculosis, Pulmonary
- SeroSelectTB rapid TB test
-
Bahir Dar, Ethiopia
- +2 more
Sep 26, 2022
HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)
Not yet recruiting
- HIV Infections
- Teropavimab
- +4 more
- (no location specified)
Feb 6, 2023
COVID-19 Disease Trial in Berlin, Hamburg (ABNCoV2 100ug, ABNCoV2 50ug)
Active, not recruiting
- COVID-19 Disease
- ABNCoV2 100ug
- ABNCoV2 50ug
-
Berlin, Germany
- +1 more
Oct 21, 2022
Duchenne Muscular Dystrophy Trial in Los Angeles, Durham, Salt Lake City (PF-06939926)
Active, not recruiting
- Duchenne Muscular Dystrophy
- PF-06939926
-
Los Angeles, California
- +19 more
Dec 12, 2022
Cartilage Damage Trial in Utrecht (Injectable Hydrogel treatment)
Recruiting
- Cartilage Damage
- Injectable Hydrogel treatment
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Feb 18, 2022
Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)
Recruiting
- Extensive-stage Small Cell Lung Cancer
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 27, 2023
Spinal Muscular Atrophy Trial (OAV101)
Recruiting
- Spinal Muscular Atrophy
- OAV101
-
Montreal, Quebec, Canada
- +1 more
Jan 31, 2023
Anaphylactic Reaction Trial in Adelaide (Epinephrine, Placebo)
Not yet recruiting
- Anaphylactic Reaction
- Epinephrine
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 22, 2023
Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)
Not yet recruiting
- Sjogrens Syndrome
- Ianalumab (VAY736)
- Placebo
- (no location specified)
Aug 3, 2023
Muscular Atrophy, Spinal Trial in Argentina, Brazil (OAV101)
Active, not recruiting
- Muscular Atrophy, Spinal
- OAV101
-
Caba, Buenos Aires, Argentina
- +4 more
Oct 2, 2022
Aphasia, Anomic Trial in London (Real tDCS, Sham tDCS)
Active, not recruiting
- Aphasia, Anomic
- Real tDCS
- Sham tDCS
-
London, Greater London, United KingdomInstitute of Cognitive Neuroscience, University College London
Oct 28, 2021
Chronic Diabetic Foot Ulcers Trial in United States (5% Bisphosphocin Topical Gel, Placebo Topical Gel, 10% Bisphosphocin
Terminated
- Chronic Diabetic Foot Ulcers
- 5% Bisphosphocin Topical Gel
- +2 more
-
Jonesboro, Arkansas
- +4 more
Jun 15, 2022
Intracranial Pressure and Cerebral Blood Flow Using
Recruiting
- Traumatic Brain Injury
- Intracranial Hypertension
- DCS
-
London, United KingdomRoyal London Hospital
Sep 8, 2023